Australians are being warned about wellness businesses making dodgy claims about the supposed benefits of intravenous infusion treatments.
IV ‘cocktails’ under regulator’s spotlight
Australians are at risk of wasting hundreds of dollars on intravenous infusion “cocktails” marketed with dodgy and misleading promises, the medical regulator warns.
The Australian Health Practitioner Regulation Agency has this week put several businesses on notice, warning their marketing tactics for intravenous infusion treatments may be against national law.
The law prohibits advertising that makes misleading or unfounded claims.
While intravenous infusion treatments are increasingly on offer in Australia, the medical justification and scientific evidence behind them has not kept pace with advertising, the agency’s chief executive Martin Fletcher said.